Pfizer has received approval from MIDC for the transfer of the business undertaking to Vidhi Research and Development LLP (Vidhi). The business undertaking includes the land, plant & machinery and employees, save and except certain portion of the land.
Earlier, the company had entered into Business Transfer Agreement for transfer of the Company’s business undertaking at Thane (BTA) as a going concern to Vidhi for a lump sum consideration of Rs 178 crore.
Pfizer has produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections.
